Global and United States Angiotensin Receptor Blockers (ARBs) Market Insights, Forecast to 2026

Publisher Name :
Date: 25-Nov-2020
No. of pages: 147
Inquire Before Buying

Angiotensin Receptor Blockers (ARBs) market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Angiotensin Receptor Blockers (ARBs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Angiotensin Receptor Blockers (ARBs) market is segmented into

- Valsartan

- Telmisartan

- Losartan

- Irbesartan

- Azilsartan

- Olmesartan

Segment by Application, the Angiotensin Receptor Blockers (ARBs) market is segmented into

- Hypertension

- Cardiovascular Diseases

- Kidney Diseases

- Other

Regional and Country-level Analysis

The Angiotensin Receptor Blockers (ARBs) market is analysed and market size information is provided by regions (countries).

The key regions covered in the Angiotensin Receptor Blockers (ARBs) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Angiotensin Receptor Blockers (ARBs) Market Share Analysis

Angiotensin Receptor Blockers (ARBs) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Angiotensin Receptor Blockers (ARBs) business, the date to enter into the Angiotensin Receptor Blockers (ARBs) market, Angiotensin Receptor Blockers (ARBs) product introduction, recent developments, etc.

The major vendors covered:

- Pfizer

- Novartis

- Merck

- Astra Zeneca

- Jhonson and Johnson

- Eli Lilly

- Sanofi

- Bristol-Myers Squibb

- Bayer

- GSK

- Teva Pharmaceutical

Global and United States Angiotensin Receptor Blockers (ARBs) Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Angiotensin Receptor Blockers (ARBs) Product Introduction
1.2 Market Segments
1.3 Key Angiotensin Receptor Blockers (ARBs) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Angiotensin Receptor Blockers (ARBs) Market Size Growth Rate by Type
1.4.2 Valsartan
1.4.3 Telmisartan
1.4.4 Losartan
1.4.5 Irbesartan
1.4.6 Azilsartan
1.4.7 Olmesartan
1.5 Market by Application
1.5.1 Global Angiotensin Receptor Blockers (ARBs) Market Size Growth Rate by Application
1.5.2 Hypertension
1.5.3 Cardiovascular Diseases
1.5.4 Kidney Diseases
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Angiotensin Receptor Blockers (ARBs) Market Size, Estimates and Forecasts
2.1.1 Global Angiotensin Receptor Blockers (ARBs) Revenue 2015-2026
2.1.2 Global Angiotensin Receptor Blockers (ARBs) Sales 2015-2026
2.2 Global Angiotensin Receptor Blockers (ARBs), Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Angiotensin Receptor Blockers (ARBs) Historical Market Size by Region (2015-2020)
2.3.1 Global Angiotensin Receptor Blockers (ARBs) Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Angiotensin Receptor Blockers (ARBs) Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Angiotensin Receptor Blockers (ARBs) Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Angiotensin Receptor Blockers (ARBs) Sales Forecast by Region (2021-2026)
2.4.2 Global Angiotensin Receptor Blockers (ARBs) Revenue Forecast by Region (2021-2026)
3 Global Angiotensin Receptor Blockers (ARBs) Competitor Landscape by Players
3.1 Global Top Angiotensin Receptor Blockers (ARBs) Sales by Manufacturers
3.1.1 Global Angiotensin Receptor Blockers (ARBs) Sales by Manufacturers (2015-2020)
3.1.2 Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Manufacturers (2015-2020)
3.2 Global Angiotensin Receptor Blockers (ARBs) Manufacturers by Revenue
3.2.1 Global Angiotensin Receptor Blockers (ARBs) Revenue by Manufacturers (2015-2020)
3.2.2 Global Angiotensin Receptor Blockers (ARBs) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Angiotensin Receptor Blockers (ARBs) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Angiotensin Receptor Blockers (ARBs) Revenue in 2019
3.2.5 Global Angiotensin Receptor Blockers (ARBs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Angiotensin Receptor Blockers (ARBs) Price by Manufacturers
3.4 Global Angiotensin Receptor Blockers (ARBs) Manufacturing Base Distribution, Product Types
3.4.1 Angiotensin Receptor Blockers (ARBs) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Angiotensin Receptor Blockers (ARBs) Product Type
3.4.3 Date of International Manufacturers Enter into Angiotensin Receptor Blockers (ARBs) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Angiotensin Receptor Blockers (ARBs) Market Size by Type (2015-2020)
4.1.1 Global Angiotensin Receptor Blockers (ARBs) Sales by Type (2015-2020)
4.1.2 Global Angiotensin Receptor Blockers (ARBs) Revenue by Type (2015-2020)
4.1.3 Angiotensin Receptor Blockers (ARBs) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Angiotensin Receptor Blockers (ARBs) Market Size Forecast by Type (2021-2026)
4.2.1 Global Angiotensin Receptor Blockers (ARBs) Sales Forecast by Type (2021-2026)
4.2.2 Global Angiotensin Receptor Blockers (ARBs) Revenue Forecast by Type (2021-2026)
4.2.3 Angiotensin Receptor Blockers (ARBs) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Angiotensin Receptor Blockers (ARBs) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Angiotensin Receptor Blockers (ARBs) Market Size by Application (2015-2020)
5.1.1 Global Angiotensin Receptor Blockers (ARBs) Sales by Application (2015-2020)
5.1.2 Global Angiotensin Receptor Blockers (ARBs) Revenue by Application (2015-2020)
5.1.3 Angiotensin Receptor Blockers (ARBs) Price by Application (2015-2020)
5.2 Angiotensin Receptor Blockers (ARBs) Market Size Forecast by Application (2021-2026)
5.2.1 Global Angiotensin Receptor Blockers (ARBs) Sales Forecast by Application (2021-2026)
5.2.2 Global Angiotensin Receptor Blockers (ARBs) Revenue Forecast by Application (2021-2026)
5.2.3 Global Angiotensin Receptor Blockers (ARBs) Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Angiotensin Receptor Blockers (ARBs) Market Size YoY Growth 2015-2026
6.1.1 United States Angiotensin Receptor Blockers (ARBs) Sales YoY Growth 2015-2026
6.1.2 United States Angiotensin Receptor Blockers (ARBs) Revenue YoY Growth 2015-2026
6.1.3 United States Angiotensin Receptor Blockers (ARBs) Market Share in Global Market 2015-2026
6.2 United States Angiotensin Receptor Blockers (ARBs) Market Size by Players (International and Local Players)
6.2.1 United States Top Angiotensin Receptor Blockers (ARBs) Players by Sales (2015-2020)
6.2.2 United States Top Angiotensin Receptor Blockers (ARBs) Players by Revenue (2015-2020)
6.3 United States Angiotensin Receptor Blockers (ARBs) Historic Market Review by Type (2015-2020)
6.3.1 United States Angiotensin Receptor Blockers (ARBs) Sales Market Share by Type (2015-2020)
6.3.2 United States Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Type (2015-2020)
6.3.3 United States Angiotensin Receptor Blockers (ARBs) Price by Type (2015-2020)
6.4 United States Angiotensin Receptor Blockers (ARBs) Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Angiotensin Receptor Blockers (ARBs) Sales Forecast by Type (2021-2026)
6.4.2 United States Angiotensin Receptor Blockers (ARBs) Revenue Forecast by Type (2021-2026)
6.4.3 United States Angiotensin Receptor Blockers (ARBs) Price Forecast by Type (2021-2026)
6.5 United States Angiotensin Receptor Blockers (ARBs) Historic Market Review by Application (2015-2020)
6.5.1 United States Angiotensin Receptor Blockers (ARBs) Sales Market Share by Application (2015-2020)
6.5.2 United States Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Application (2015-2020)
6.5.3 United States Angiotensin Receptor Blockers (ARBs) Price by Application (2015-2020)
6.6 United States Angiotensin Receptor Blockers (ARBs) Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Angiotensin Receptor Blockers (ARBs) Sales Forecast by Application (2021-2026)
6.6.2 United States Angiotensin Receptor Blockers (ARBs) Revenue Forecast by Application (2021-2026)
6.6.3 United States Angiotensin Receptor Blockers (ARBs) Price Forecast by Application (2021-2026)
7 North America
7.1 North America Angiotensin Receptor Blockers (ARBs) Market Size YoY Growth 2015-2026
7.2 North America Angiotensin Receptor Blockers (ARBs) Market Facts & Figures by Country
7.2.1 North America Angiotensin Receptor Blockers (ARBs) Sales by Country (2015-2020)
7.2.2 North America Angiotensin Receptor Blockers (ARBs) Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Angiotensin Receptor Blockers (ARBs) Market Size YoY Growth 2015-2026
8.2 Europe Angiotensin Receptor Blockers (ARBs) Market Facts & Figures by Country
8.2.1 Europe Angiotensin Receptor Blockers (ARBs) Sales by Country
8.2.2 Europe Angiotensin Receptor Blockers (ARBs) Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Angiotensin Receptor Blockers (ARBs) Market Size YoY Growth 2015-2026
9.2 Asia Pacific Angiotensin Receptor Blockers (ARBs) Market Facts & Figures by Country
9.2.1 Asia Pacific Angiotensin Receptor Blockers (ARBs) Sales by Region (2015-2020)
9.2.2 Asia Pacific Angiotensin Receptor Blockers (ARBs) Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Angiotensin Receptor Blockers (ARBs) Market Size YoY Growth 2015-2026
10.2 Latin America Angiotensin Receptor Blockers (ARBs) Market Facts & Figures by Country
10.2.1 Latin America Angiotensin Receptor Blockers (ARBs) Sales by Country
10.2.2 Latin America Angiotensin Receptor Blockers (ARBs) Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Angiotensin Receptor Blockers (ARBs) Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Angiotensin Receptor Blockers (ARBs) Market Facts & Figures by Country
11.2.1 Middle East and Africa Angiotensin Receptor Blockers (ARBs) Sales by Country
11.2.2 Middle East and Africa Angiotensin Receptor Blockers (ARBs) Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Angiotensin Receptor Blockers (ARBs) Products Offered
12.1.5 Pfizer Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Description and Business Overview
12.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novartis Angiotensin Receptor Blockers (ARBs) Products Offered
12.2.5 Novartis Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Description and Business Overview
12.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merck Angiotensin Receptor Blockers (ARBs) Products Offered
12.3.5 Merck Recent Development
12.4 Astra Zeneca
12.4.1 Astra Zeneca Corporation Information
12.4.2 Astra Zeneca Description and Business Overview
12.4.3 Astra Zeneca Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Astra Zeneca Angiotensin Receptor Blockers (ARBs) Products Offered
12.4.5 Astra Zeneca Recent Development
12.5 Jhonson and Johnson
12.5.1 Jhonson and Johnson Corporation Information
12.5.2 Jhonson and Johnson Description and Business Overview
12.5.3 Jhonson and Johnson Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Products Offered
12.5.5 Jhonson and Johnson Recent Development
12.6 Eli Lilly
12.6.1 Eli Lilly Corporation Information
12.6.2 Eli Lilly Description and Business Overview
12.6.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Eli Lilly Angiotensin Receptor Blockers (ARBs) Products Offered
12.6.5 Eli Lilly Recent Development
12.7 Sanofi
12.7.1 Sanofi Corporation Information
12.7.2 Sanofi Description and Business Overview
12.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Sanofi Angiotensin Receptor Blockers (ARBs) Products Offered
12.7.5 Sanofi Recent Development
12.8 Bristol-Myers Squibb
12.8.1 Bristol-Myers Squibb Corporation Information
12.8.2 Bristol-Myers Squibb Description and Business Overview
12.8.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Products Offered
12.8.5 Bristol-Myers Squibb Recent Development
12.9 Bayer
12.9.1 Bayer Corporation Information
12.9.2 Bayer Description and Business Overview
12.9.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Bayer Angiotensin Receptor Blockers (ARBs) Products Offered
12.9.5 Bayer Recent Development
12.10 GSK
12.10.1 GSK Corporation Information
12.10.2 GSK Description and Business Overview
12.10.3 GSK Sales, Revenue and Gross Margin (2015-2020)
12.10.4 GSK Angiotensin Receptor Blockers (ARBs) Products Offered
12.10.5 GSK Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Pfizer Angiotensin Receptor Blockers (ARBs) Products Offered
12.11.5 Pfizer Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Angiotensin Receptor Blockers (ARBs) Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Angiotensin Receptor Blockers (ARBs) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Angiotensin Receptor Blockers (ARBs) Market Segments
Table 2. Ranking of Global Top Angiotensin Receptor Blockers (ARBs) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Angiotensin Receptor Blockers (ARBs) Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Valsartan
Table 5. Major Manufacturers of Telmisartan
Table 6. Major Manufacturers of Losartan
Table 7. Major Manufacturers of Irbesartan
Table 8. Major Manufacturers of Azilsartan
Table 9. Major Manufacturers of Olmesartan
Table 10. Global Angiotensin Receptor Blockers (ARBs) Market Size Growth Rate by Application 2020-2026 (K MT)
Table 11. Global Angiotensin Receptor Blockers (ARBs) Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 12. Global Angiotensin Receptor Blockers (ARBs) Sales by Regions 2015-2020 (K MT)
Table 13. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Regions (2015-2020)
Table 14. Global Angiotensin Receptor Blockers (ARBs) Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Angiotensin Receptor Blockers (ARBs) Sales Forecast by Region (2021-2026) (K MT)
Table 16. Global Angiotensin Receptor Blockers (ARBs) Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Angiotensin Receptor Blockers (ARBs) Sales Share by Manufacturers (2015-2020)
Table 18. Global Angiotensin Receptor Blockers (ARBs) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Angiotensin Receptor Blockers (ARBs) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Angiotensin Receptor Blockers (ARBs) as of 2019)
Table 20. Angiotensin Receptor Blockers (ARBs) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Angiotensin Receptor Blockers (ARBs) Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Angiotensin Receptor Blockers (ARBs) Price (2015-2020) (USD/Unit)
Table 23. Angiotensin Receptor Blockers (ARBs) Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Angiotensin Receptor Blockers (ARBs) Product Type
Table 25. Date of International Manufacturers Enter into Angiotensin Receptor Blockers (ARBs) Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Angiotensin Receptor Blockers (ARBs) Sales by Type (2015-2020) (K MT)
Table 28. Global Angiotensin Receptor Blockers (ARBs) Sales Share by Type (2015-2020)
Table 29. Global Angiotensin Receptor Blockers (ARBs) Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Angiotensin Receptor Blockers (ARBs) Revenue Share by Type (2015-2020)
Table 31. Angiotensin Receptor Blockers (ARBs) Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Angiotensin Receptor Blockers (ARBs) Sales Share by Type (2021-2026)
Table 33. Global Angiotensin Receptor Blockers (ARBs) Sales by Application (2015-2020) (K MT)
Table 34. Global Angiotensin Receptor Blockers (ARBs) Sales Share by Application (2015-2020)
Table 35. Global Angiotensin Receptor Blockers (ARBs) Sales Share by Application (2021-2026)
Table 36. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share Forecast by Application (2021-2026)
Table 37. Global Angiotensin Receptor Blockers (ARBs) Revenue by Application (2015-2020) (US$ Million)
Table 38. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share Forecast by Application (2021-2026)
Table 39. United States Angiotensin Receptor Blockers (ARBs) Sales (K MT) of Key Companies (2015-2020)
Table 40. United States Angiotensin Receptor Blockers (ARBs) Sales Share by Company (2015-2020)
Table 41. United States Angiotensin Receptor Blockers (ARBs) Revenue (US$ Million) by Company (2015-2020)
Table 42. United States Angiotensin Receptor Blockers (ARBs) Sales (K MT) by Type (2015-2020)
Table 43. United States Angiotensin Receptor Blockers (ARBs) Sales Share by Type (2015-2020)
Table 44. United States Angiotensin Receptor Blockers (ARBs) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 45. United States Angiotensin Receptor Blockers (ARBs) Price (K MT) by Type (2015-2020)
Table 46. United States Angiotensin Receptor Blockers (ARBs) Sales (K MT) by Type (2021-2026)
Table 47. United States Angiotensin Receptor Blockers (ARBs) Sales Share by Type (2021-2026)
Table 48. United States Angiotensin Receptor Blockers (ARBs) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 49. United States Angiotensin Receptor Blockers (ARBs) Revenue Share by Type (2021-2026)
Table 50. United States Angiotensin Receptor Blockers (ARBs) Price (K MT) by Type (2021-2026)
Table 51. United States Angiotensin Receptor Blockers (ARBs) Sales (K MT) by Application (2015-2020)
Table 52. United States Angiotensin Receptor Blockers (ARBs) Sales Share by Application (2015-2020)
Table 53. United States Angiotensin Receptor Blockers (ARBs) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 54. United States Angiotensin Receptor Blockers (ARBs) Sales (K MT) by Application (2021-2026)
Table 55. United States Angiotensin Receptor Blockers (ARBs) Sales Share by Application (2021-2026)
Table 56. United States Angiotensin Receptor Blockers (ARBs) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 57. United States Angiotensin Receptor Blockers (ARBs) Revenue Share by Application (2021-2026)
Table 58. North America Angiotensin Receptor Blockers (ARBs) Sales by Country (2015-2020) (K MT)
Table 59. North America Angiotensin Receptor Blockers (ARBs) Sales Market Share by Country (2015-2020)
Table 60. North America Angiotensin Receptor Blockers (ARBs) Revenue by Country (2015-2020) (US$ Million)
Table 61. North America Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Country (2015-2020)
Table 62. Europe Angiotensin Receptor Blockers (ARBs) Sales by Country (2015-2020) (K MT)
Table 63. Europe Angiotensin Receptor Blockers (ARBs) Sales Market Share by Country (2015-2020)
Table 64. Europe Angiotensin Receptor Blockers (ARBs) Revenue by Country (2015-2020) (US$ Million)
Table 65. Europe Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Country (2015-2020)
Table 66. Asia Pacific Angiotensin Receptor Blockers (ARBs) Sales by Region (2015-2020) (K MT)
Table 67. Asia Pacific Angiotensin Receptor Blockers (ARBs) Sales Market Share by Region (2015-2020)
Table 68. Asia Pacific Angiotensin Receptor Blockers (ARBs) Revenue by Region (2015-2020) (US$ Million)
Table 69. Asia Pacific Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Region (2015-2020)
Table 70. Latin America Angiotensin Receptor Blockers (ARBs) Sales by Country (2015-2020) (K MT)
Table 71. Latin America Angiotensin Receptor Blockers (ARBs) Sales Market Share by Country (2015-2020)
Table 72. Latin Americaa Angiotensin Receptor Blockers (ARBs) Revenue by Country (2015-2020) (US$ Million)
Table 73. Latin America Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa Angiotensin Receptor Blockers (ARBs) Sales by Country (2015-2020) (K MT)
Table 75. Middle East and Africa Angiotensin Receptor Blockers (ARBs) Sales Market Share by Country (2015-2020)
Table 76. Middle East and Africa Angiotensin Receptor Blockers (ARBs) Revenue by Country (2015-2020) (US$ Million)
Table 77. Middle East and Africa Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Country (2015-2020)
Table 78. Pfizer Corporation Information
Table 79. Pfizer Description and Business Overview
Table 80. Pfizer Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Pfizer Angiotensin Receptor Blockers (ARBs) Product
Table 82. Pfizer Recent Development
Table 83. Novartis Corporation Information
Table 84. Novartis Description and Business Overview
Table 85. Novartis Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Novartis Product
Table 87. Novartis Recent Development
Table 88. Merck Corporation Information
Table 89. Merck Description and Business Overview
Table 90. Merck Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Merck Product
Table 92. Merck Recent Development
Table 93. Astra Zeneca Corporation Information
Table 94. Astra Zeneca Description and Business Overview
Table 95. Astra Zeneca Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Astra Zeneca Product
Table 97. Astra Zeneca Recent Development
Table 98. Jhonson and Johnson Corporation Information
Table 99. Jhonson and Johnson Description and Business Overview
Table 100. Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Jhonson and Johnson Product
Table 102. Jhonson and Johnson Recent Development
Table 103. Eli Lilly Corporation Information
Table 104. Eli Lilly Description and Business Overview
Table 105. Eli Lilly Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Eli Lilly Product
Table 107. Eli Lilly Recent Development
Table 108. Sanofi Corporation Information
Table 109. Sanofi Description and Business Overview
Table 110. Sanofi Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Sanofi Product
Table 112. Sanofi Recent Development
Table 113. Bristol-Myers Squibb Corporation Information
Table 114. Bristol-Myers Squibb Description and Business Overview
Table 115. Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Bristol-Myers Squibb Product
Table 117. Bristol-Myers Squibb Recent Development
Table 118. Bayer Corporation Information
Table 119. Bayer Description and Business Overview
Table 120. Bayer Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. Bayer Product
Table 122. Bayer Recent Development
Table 123. GSK Corporation Information
Table 124. GSK Description and Business Overview
Table 125. GSK Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 126. GSK Product
Table 127. GSK Recent Development
Table 128. Teva Pharmaceutical Corporation Information
Table 129. Teva Pharmaceutical Description and Business Overview
Table 130. Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 131. Teva Pharmaceutical Product
Table 132. Teva Pharmaceutical Recent Development
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Angiotensin Receptor Blockers (ARBs) Players
Table 137. Angiotensin Receptor Blockers (ARBs) Customers List
Table 138. Angiotensin Receptor Blockers (ARBs) Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Angiotensin Receptor Blockers (ARBs) Product Picture
Figure 2. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Type in 2020 & 2026
Figure 3. Valsartan Product Picture
Figure 4. Telmisartan Product Picture
Figure 5. Losartan Product Picture
Figure 6. Irbesartan Product Picture
Figure 7. Azilsartan Product Picture
Figure 8. Olmesartan Product Picture
Figure 9. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Application in 2020 & 2026
Figure 10. Hypertension
Figure 11. Cardiovascular Diseases
Figure 12. Kidney Diseases
Figure 13. Other
Figure 14. Angiotensin Receptor Blockers (ARBs) Report Years Considered
Figure 15. Global Angiotensin Receptor Blockers (ARBs) Market Size 2015-2026 (US$ Million)
Figure 16. Global Angiotensin Receptor Blockers (ARBs) Sales 2015-2026 (K MT)
Figure 17. Global Angiotensin Receptor Blockers (ARBs) Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Region (2015-2020)
Figure 19. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Region in 2019
Figure 20. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Region (2015-2020)
Figure 21. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Region in 2019
Figure 22. Global Angiotensin Receptor Blockers (ARBs) Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Angiotensin Receptor Blockers (ARBs) Revenue in 2019
Figure 24. Angiotensin Receptor Blockers (ARBs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Type (2015-2020)
Figure 26. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Type in 2019
Figure 27. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Type (2015-2020)
Figure 28. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Type in 2019
Figure 29. Global Angiotensin Receptor Blockers (ARBs) Market Share by Price Range (2015-2020)
Figure 30. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Application (2015-2020)
Figure 31. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Application in 2019
Figure 32. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Application (2015-2020)
Figure 33. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Application in 2019
Figure 34. United States Angiotensin Receptor Blockers (ARBs) Sales Growth Rate 2015-2026 (K MT)
Figure 35. United States Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate 2015-2026 (US$ Million)
Figure 36. United States Angiotensin Receptor Blockers (ARBs) Market Share in Global Market 2015-2026
Figure 37. United States 5 and 10 Largest Angiotensin Receptor Blockers (ARBs) Players Market Share by Revenue in Angiotensin Receptor Blockers (ARBs) in 2019
Figure 38. United States Angiotensin Receptor Blockers (ARBs) Revenue Share by Type (2015-2020)
Figure 39. United States Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate by Type in 2015 & 2019
Figure 40. United States Angiotensin Receptor Blockers (ARBs) Revenue Share by Application (2015-2020)
Figure 41. United States Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate by Application in 2015 & 2019
Figure 42. North America Angiotensin Receptor Blockers (ARBs) Sales Growth Rate 2015-2020 (K MT)
Figure 43. North America Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. North America Angiotensin Receptor Blockers (ARBs) Sales Market Share by Country in 2019
Figure 45. North America Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Country in 2019
Figure 46. U.S. Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 47. U.S. Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Canada Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 49. Canada Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Europe Angiotensin Receptor Blockers (ARBs) Sales Growth Rate 2015-2020 (K MT)
Figure 51. Europe Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 52. Europe Angiotensin Receptor Blockers (ARBs) Sales Market Share by Country in 2019
Figure 53. Europe Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Country in 2019
Figure 54. Germany Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 55. Germany Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. France Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 57. France Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. U.K. Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 59. U.K. Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Italy Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 61. Italy Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Russia Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 63. Russia Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Asia Pacific Angiotensin Receptor Blockers (ARBs) Sales Growth Rate 2015-2020 (K MT)
Figure 65. Asia Pacific Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 66. Asia Pacific Angiotensin Receptor Blockers (ARBs) Sales Market Share by Region in 2019
Figure 67. Asia Pacific Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Region in 2019
Figure 68. China Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 69. China Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Japan Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 71. Japan Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. South Korea Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 73. South Korea Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. India Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 75. India Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Australia Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 77. Australia Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Taiwan Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 79. Taiwan Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Indonesia Angiotensin Receptor Blockers (ARBs) Sales Growth Rate (2015-2020) (K MT)
Figure 81. Indonesia Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Thailand Angiotensin Receptor Blockers (ARBs) Sales
  • Global Recombinant Human Erythropoietin (rhEPO) Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 99
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - ESRD - Cancer - HIV - Wounds and Neural Disease Segment by Application - Hospi......
  • Global rhEPO Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 97
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - ESRD - Cancer - HIV - Wounds and neural disease Segment by Application - Hospi......
  • Global Rhematoid Arthritis Drugs Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 94
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Pharmaceuticals - Biopharmaceuticals Segment by Application - Prescription - OTC......
  • Global Chronic Obstructive Pulmonary Disease Drugs Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 118
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Inhalers - Nebulizers Segment by Application - Emphysema - Chronic Bronchitis ......
  • Global Chronic Lymphocytic Leukemia Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 121
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Acutemyeloid (ormyelogenous)leukemia (AML) - Chronicmyeloid (ormyelogenous)leukemia (CML) - Acutelymphocyti......
  • Global Chemotherapy-induced Nausea and Vomiting Drugs Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 93
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - 5-HT3 Inhibitors - NK1 Inhibitors - Other Segment by Application - Highly Emetogenic ......
  • Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 120
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Aloxi (Palonosetron) - Kytril Generic (Granisetron) - Emend (Aprepitant) - Akynzeo (Netupitant-Palon......
  • Global ß-blockers Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 122
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Nonselective Agents - Selective Agents Segment by Application - Abnormal Heart Rhythms......
  • Global a-adrenoreceptor Antagonists Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 116
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Non-selective Antagonists - Selective Antagonists Segment by Application - Hypertension......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs